Cargando…
Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats
Given the limited efficacy of available pharmacotherapies for treatment of alcohol use disorder (AUD), the need for new medications is substantial. Preclinical studies have shown that acute administration of glucagon-like peptide-1 receptor (GLP-1R) agonists inhibits various ethanol-related behaviou...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367312/ https://www.ncbi.nlm.nih.gov/pubmed/32678077 http://dx.doi.org/10.1038/s41398-020-00923-1 |